Nucleus RadioPharma Appoints Former McKesson, Novo Nordisk Executive Kathy Spencer-Pike as Chief Commercial Officer to Drive Business Growth
Position
Chief Commercial Officer
Company
Nucleus RadioPharma
DavidsonManufacturingBiotechnologyHealth CarepharmaceuticalsDescription
Nucleus RadioPharma, a fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, announced the appointment of Kathy Spencer-Pike as Chief Commercial Officer. As a seasoned veteran with decades of commercial experience at McKesson, Novo Nordisk, Sanofi and Pfizer, Spencer-Pike will be responsible for accelerating the growth of the startup following its oversubscribed $56M Series A in October.
Quick answer
Nucleus RadioPharma Appoints Former McKesson, Novo Nordisk Executive Kathy Spencer-Pike as Chief Commercial Officer to Drive Business Growth (December 14, 2023). Nucleus RadioPharma is based in Davidson, North Carolina, United States.
- Who is the new Chief Commercial Officer at Nucleus RadioPharma?
- Nucleus RadioPharma named Kathy Spencer-Pike Chief Commercial Officer, announced December 14, 2023.
- What did Nucleus RadioPharma announce on December 14, 2023?
- Nucleus RadioPharma, a fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, announced the appointment of Kathy Spencer-Pike as Chief Commercial Officer. As a seasoned veteran with decades of commercial experience at McKesson, Novo Nordisk, Sanofi and Pfizer, Spencer-Pike will be responsible for accelerating the growth of the startup following its oversubscribed $56M...
- What does Nucleus RadioPharma do?
- Nucleus RadioPharma is an innovative CDMO dedicated to the development and manufacturing of targeted radiotherapies.
- Where is Nucleus RadioPharma based?
- Nucleus RadioPharma is based in Davidson, North Carolina, United States.
- Which similar companies made leadership changes around the same time?
- Intensity Therapeutics (December 12, 2023), Electra Therapeutics (December 11, 2023), Philip Morris International (December 19, 2023) and The Hain Celestial Group (December 19, 2023) also announced leadership changes within 45 days of Nucleus RadioPharma.
Source: Fundz verified event record.
Other recent leadership changes in pharmaceuticals and Manufacturing
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Intensity Therapeutics Appoints Joseph Talamo, CPA, as Chief Financial Officer (December 12, 2023)
- Electra Therapeutics Appoints Kathy Dong, PharmD, MBA, as President and Chief Executive Officer (December 11, 2023)
- Philip Morris International Announces Senior Global Communications Leadership Changes (December 19, 2023)
- Hain Celestial Group Announces Amber Jefferson as New Chief People Officer (December 19, 2023)
- Santhera Appoints Executive Committee Members as it Transitions into Commercial Stage (December 7, 2023)
- Caldera Medical Appoints John Pitstick as CFO to Spearhead Financial Strategy and M&A Activity During Rapid Expansion (December 5, 2023)
Who to call at Nucleus RadioPharma, and when
A new leader at Nucleus RadioPharma brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Nucleus RadioPharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nucleus RadioPharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nucleus RadioPharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nucleus RadioPharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Nucleus RadioPharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.